Homology Modelling of Human E1 Ubiquitin Activating Enzyme

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|7|1|57-62

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.7, Iss.1, 2010-01, pp. : 57-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers

By  

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 130-135

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3201-3209

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Procarcinogen Activating Enzyme CYP1A2 Activity and Free Radical Formation by Caffeic Acid and its Amide Analogues

By  

Drug Metabolism Letters, Vol. 10, Iss. 3, 2016-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite

RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer

By  

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 157-174

Bentham Science Publishers

Access to resources Recommend Favorite

Nociceptin activation of the human ORL 1 receptor expressed in Chinese hamster ovary cells: Functional homology with opioid receptors

By Fawzi A.B.   Zhang H.   Weig B.   Hawes B.   Graziano M.P.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 233-242

Elsevier

Access to resources Recommend Favorite